Literature DB >> 2857133

Interaction of estramustine phosphate with microtubule-associated proteins.

M Wallin, J Deinum, B Fridén.   

Abstract

We have reported [(1984) Cancer Res., in press] that estramustine phosphate inhibits microtubule assembly and disassembled preformed microtubules. We now present evidence that estramustine phosphate inhibits microtubule assembly by binding to the microtubule-associated proteins. We have found that: additional microtubule-associated proteins relieved the inhibition of assembly by estramustine phosphate; 3H-labelled estramustine phosphate bound predominantly to the microtubule-associated proteins; and the content of the microtubule-associated proteins was reduced in taxol reversed estramustine phosphate-inhibited microtubules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857133     DOI: 10.1016/0014-5793(85)80536-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.

Authors:  K D Tew; M E Stearns
Journal:  Urol Res       Date:  1987

2.  Dependency of microtubule-associated proteins (MAPs) for tubulin stability and assembly; use of estramustine phosphate in the study of microtubules.

Authors:  B Fridén; M Wallin
Journal:  Mol Cell Biochem       Date:  1991-07-10       Impact factor: 3.396

3.  The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner.

Authors:  Anders Holm; Per-Olof Grände; Richard F Ludueña; Björn Olde; Veena Prasad; L M Fredrik Leeb-Lundberg; Bengt-Olof Nilsson
Journal:  Mol Cell Biochem       Date:  2012-03-27       Impact factor: 3.396

4.  Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.

Authors:  D Panda; H P Miller; K Islam; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Estramustine phosphate reversibly inhibits an early stage during adenovirus replication.

Authors:  E Everitt; H Ekstrand; B Boberg; B Hartley-Asp
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.

Authors:  P Behnam-Motlagh; O Jonsson; K G Engström; R Henriksson; K Grankvist
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.

Authors:  R J D'Amato; C M Lin; E Flynn; J Folkman; E Hamel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Dansylated estramustine, a fluorescent probe for studies of estramustine uptake and identification of intracellular targets.

Authors:  M E Stearns; D P Jenkins; K D Tew
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.

Authors:  J Martínez; J F Santibáñez; C Vial; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1992-11-18       Impact factor: 3.396

10.  Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r.

Authors:  M Hansenson; B Lundh; B Hartley-Asp; A Pousette
Journal:  Urol Res       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.